STOCK TITAN

TC Biopharm (Holdings) WTS (TCBWF) Stock Price, News & Analysis

TCBWF OTC
Published by Stock Titan Data refreshed

What Changed

Price Move History

Daily moves over 5%
44 65 sessions, March 24, 2025 to March 18, 2026
Largest daily move
+456.3% close of April 29, 2025
1-month change
+80% closing prices, February 18, 2026 to March 18, 2026

Company Description

TCBWF gained 800.0% in the year to March 18, 2026. The last closing price was $0.0018.

For FY2024, TC Biopharm (Holdings) WTS reported net income of -$15.2M and diluted earnings per share of -$0.04.

This page collects what Stock Titan holds for TCBWF, including price data, SEC filings, financial highlights, and short interest trends.

Stock Performance

$0.0018
No recent trading
Last close: March 18, 2026
+800%
Year to March 18, 2026

TC Biopharm (Holdings) WTS (TCBWF) closed at $0.0018 on March 18, 2026. In the year to March 18, 2026, the price gained 800.0%.

See what a $1,000 investment in TCBWF would be worth today

Average down calculator for TCBWF

TCBWF Metrics & Rankings

Price returns through March 18, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

No recent news available for TCBWF.

SEC Filings

TC Biopharm (Holdings) WTS has filed 2 recent SEC filings, including 1 Form 15-12G, 1 Form 6-K. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all TCBWF SEC filings →

Financial Highlights

TC Biopharm (Holdings) WTS reported operating income of -$16.0M in FY2024, and net income was -$15.2M. Diluted earnings per share stood at -$0.04. The company generated -$15.7M in operating cash flow. The current ratio was 1.39, measuring current assets divided by current liabilities.

-$15.2M
Net Income (FY2024)
-$15.7M
Operating Cash Flow
—
Revenue (FY2024)

Upcoming Events

No upcoming events scheduled for TCBWF.

Short Interest History

Last 12 Months

Short interest in TC Biopharm (Holdings) WTS (TCBWF) currently stands at 729 shares.

Days to Cover History

Last 12 Months

Days to cover for TC Biopharm (Holdings) WTS (TCBWF) currently stands at 1000.0 days. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has increased by 64001.9%. Across the settlements charted above, it has ranged from 1.0 to 1000.0 days.

Frequently Asked Questions

TC Biopharm (Holdings) WTS (TCBWF) has no recent trading. Its last close was $0.0018 on March 18, 2026.

The FY2024 net income of TC Biopharm (Holdings) WTS (TCBWF) is -$15.2M, from its most recent completed fiscal year.

The diluted earnings per share (EPS) of TC Biopharm (Holdings) WTS (TCBWF) is -$0.04 for FY2024, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of TC Biopharm (Holdings) WTS (TCBWF) is -$15.7M for FY2024, its most recent completed fiscal year. Learn about cash flow.

The current ratio of TC Biopharm (Holdings) WTS (TCBWF), current assets divided by current liabilities, was 1.39 at the end of FY2024, its most recent completed fiscal year. Learn about liquidity ratios.

The operating income of TC Biopharm (Holdings) WTS (TCBWF) is -$16.0M for FY2024, its most recent completed fiscal year. Learn about operating income.